1,041 material Form 8-K filings that 824 companies we cover made with the SEC in November 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ovintiv Inc. and its subsidiary Ovintiv Canada ULC signed an Arrangement Agreement dated November 4, 2025 to acquire NuVista Energy Ltd. in a transaction paying a mix of cash and Ovintiv common stock, subject to NuVista shareholder approval, court approval and regulatory clearances. The filing states that the deal is not complete and that closing depends on conditions that include approval under Canada's Competition Act and Investment Canada Act, with an outside date of May 4, 2026.
NuVista shareholders can elect C$18.00 in cash or 0.344 of an Ovintiv share per NuVista share, or a combination, subject to pro-ration; on a fully pro-rated basis, each share receives about C$9.00 in cash and 0.172 of an Ovintiv share
Ovintiv may issue up to 29,977,258 shares of common stock and up to C$1,568,577,429 in cash
Closing requires approval by at least 66 2/3% of votes cast by NuVista shareholders and approval by the Court of King's Bench of Alberta
A C$130 million termination fee is payable by NuVista to Ovintiv Canada in certain circumstances, and a C$130 million reverse termination fee is payable by Ovintiv Canada to NuVista in specified regulatory-failure circumstances
Coca-Cola Consolidated bought all 18.8 million shares held by a subsidiary of The Coca-Cola Company for approximately $2.4 billion, with the purchase closing on November 7, 2025. The company funded it with cash on hand and a $1.2 billion 364-day bridge term loan, and its board cut the share repurchase program from $1 billion to $400 million. For shareholders, the deal ends the stock rights agreement with The Coca-Cola Company and removes that holder, but it adds $1.2 billion of new borrowing.
Purchased 18.8 million shares at $127 per share, for about $2.4 billion, under an agreement dated November 7, 2025.
Funded with cash on hand and a $1.2 billion 364-day Wells Fargo bridge loan, which bears interest at Term SOFR plus 1.000% based on the current debt rating.
Elaine Bowers Coventry resigned from the board effective at closing, and The Coca-Cola Company gave up its board seat.
Share repurchase authorization reduced from $1 billion to $400 million, with about $136.3 million remaining.
Tesla shareholders approved the amended 2019 Equity Incentive Plan and a performance-based restricted stock award to CEO Elon Musk at the November 6, 2025 annual meeting. The shareholders did not approve the amendments to remove supermajority voting requirements, and the x.AI investment proposal was not approved under the bylaw standard despite more votes for than against.
CEO award covers 423,743,904 shares, or 12% of the adjusted share count, with a preliminary fair value estimate of $87.75 billion; vesting depends on market capitalization milestones from $2 trillion to $8.5 trillion and operational goals.
Approved for: the equity plan (1,942,926,670 for, 514,568,170 against) and the CEO award (1,892,235,822 for, 564,940,908 against).
Not approved: supermajority voting repeal (1,309,549,644 for, 955,682,310 against, 181,764,443 abstained).
Shareholder proposal on an x.AI Corp. investment received 1,058,999,435 for and 916,321,296 against, with 473,073,200 abstentions; not approved under the bylaw standard, and the Board will consider next steps.
Kratos signed a merger agreement on November 4, 2025 to acquire Orbit Technologies Ltd, an Israel-based satellite communications provider listed on the Tel Aviv Stock Exchange, for $13.725 per share in cash, or about $356.3 million in total. The company said the deal will be funded from cash on its balance sheet, and closing is expected by the end of March 2026, subject to conditions including Orbit shareholder approval and regulatory approvals in Israel.
Orbit shareholders would receive $13.725 per share in cash; aggregate consideration is expected to be about $356.3 million.
Closing is expected by the end of March 2026 and requires majority Orbit shareholder approval, Israel Competition Authority approval, and approval of the Israeli Ministry of Defense.
Orbit would pay Kratos a termination fee of $14,252,000 in certain circumstances, such as accepting a superior proposal.
Either party may terminate if the merger is not completed within 270 days of the agreement date; Orbit would report through Kratos' Microwave Electronics Division.
STAAR Surgical entered into an amendment to its merger agreement with Alcon that allows the company to actively solicit rival acquisition proposals through December 6, 2025. The company also postponed its stockholder vote on the Alcon merger to December 19, 2025, and the amendment sets the termination fee at $0 in certain superior-offer scenarios, which affects shareholders' choices in the pending deal.
Go-shop period runs from November 7, 2025 until 11:59 p.m. Eastern Time on December 6, 2025
Alcon waives matching rights for any superior offer; STAAR must give Alcon four business days' notice before terminating to accept one
Termination fee is $0 if STAAR terminates to accept a superior proposal from a Qualified Bidder, or in certain circumstances where a deal is signed within 12 months
Special meeting to vote on the Alcon merger moved from December 3, 2025 to December 19, 2025 at 8:30 a.m. Pacific Time; record date remains October 24, 2025
Stewart subsidiary SISCO Holdings agreed on November 6, 2025 to acquire Mortgage Contracting Services (MCS) through a merger, paying $330 million in cash from company resources. The company expects the deal to close before the end of the year, subject to customary conditions and the Hart-Scott-Rodino antitrust waiting period, and expects it to be immediately accretive. For shareholders, the deal commits $330 million of cash and adds property preservation services for mortgage servicers and lenders.
Purchase price: $330 million in cash, funded with available company resources
Agreement dated November 6, 2025, with MCS becoming a wholly-owned subsidiary of SISCO Holdings at closing
Expected to close before the end of the year, subject to closing conditions and HSR waiting period expiration
Company expects the transaction to be immediately accretive; MCS division will operate as a standalone company
Koppers reported third quarter 2025 net sales of $485.3 million, down 12.4% from $554.3 million a year earlier, and adjusted EBITDA of $70.9 million, down from $77.4 million. GAAP diluted EPS rose to $1.17 from $1.09, but adjusted EPS fell to $1.21 from $1.37. The company cut its 2025 sales forecast to about $1.9 billion from $1.9 billion to $2.0 billion and set adjusted EBITDA guidance of $255 million to $260 million and adjusted EPS of $4.00 to $4.15.
Q3 2025 net sales were $485.3 million vs. $554.3 million, and adjusted EBITDA was $70.9 million vs. $77.4 million.
GAAP diluted EPS was $1.17 vs. $1.09; adjusted EPS was $1.21 vs. $1.37.
2025 sales forecast revised to about $1.9 billion, from $1.9 billion to $2.0 billion previously.
2025 adjusted EBITDA guidance is $255 million to $260 million and adjusted EPS guidance is $4.00 to $4.15; the CEO expects adjusted EPS in the lower half of the previous range.
Strategy Inc agreed on November 6, 2025 to sell 7,750,000 shares of its 10.00% Series A Perpetual Stream Preferred Stock (STRE) at €80.00 per share in an underwritten offering, with gross proceeds of about €620.0 million ($715.1 million). The company estimates net proceeds of about $702.2 million, which it plans to use for general corporate purposes, including acquiring bitcoin and working capital, with settlement scheduled for November 13, 2025.
7,750,000 shares of 10.00% Series A Perpetual Stream Preferred Stock (STRE) priced at €80.00 per share on November 6, 2025
Gross proceeds of approximately €620.0 million ($715.1 million); estimated net proceeds of approximately $702.2 million
Settlement scheduled for November 13, 2025, subject to customary closing conditions
Regular dividends are payable only when declared; unpaid dividends compound, with the rate rising to a maximum of 18% per annum
TDS reported third-quarter 2025 operating revenues from continuing operations of $308.5 million, down from $327.5 million a year earlier, while diluted earnings per share from continuing operations rose to $0.33 from a loss of $0.88. The company also authorized a new $500 million share repurchase program and named Anthony Carlson president and CEO of Array effective November 16, 2025.
Q3 2025 operating revenues from continuing operations: $308.5 million, versus $327.5 million in Q3 2024
Diluted EPS from continuing operations: $0.33, versus $(0.88) a year earlier
Net loss attributable to TDS common shareholders: $(99.1) million for the quarter, per the filing's income statement, including $(139.3) million from discontinued operations
New $500 million share repurchase program, with no expiration; TDS repurchased 1,077,564 shares for $40.7 million in Q3
DoubleVerify reported third-quarter 2025 revenue of $188.6 million, up 11% from a year earlier, with adjusted EBITDA of $65.9 million at a 35% margin. Net income fell to $10.2 million from $18.2 million, and diluted EPS was $0.06 versus $0.10. The company raised its full-year 2025 adjusted EBITDA margin guidance to approximately 33% from 32% and expects full-year revenue growth of approximately 14%.
Q3 2025 revenue of $188.6 million, up 11%; activation revenue $106.7 million, up 10%
Net income of $10.2 million versus $18.2 million in Q3 2024; diluted EPS $0.06 versus $0.10
Full-year 2025 adjusted EBITDA margin guidance raised to approximately 33% from 32%
Q4 2025 revenue guidance of $207 million to $211 million; adjusted EBITDA of $77 million to $81 million
Essent Group reported third-quarter 2025 net income of $164.2 million, or $1.67 per diluted share, down from $176.2 million, or $1.65 per diluted share, a year earlier. Total revenues were $311.8 million, compared with $316.6 million in the prior-year quarter, and the Board declared a $0.31 quarterly dividend and approved a new $500 million share repurchase authorization.
Net income was $164.2 million versus $176.2 million a year earlier, while diluted EPS rose to $1.67 from $1.65.
Total revenues were $311.8 million versus $316.6 million in Q3 2024.
Quarterly dividend of $0.31 per share is payable December 10, 2025, to holders of record on December 1, 2025.
Through October 31, the company had repurchased 8.7 million shares for $501 million; a $500 million authorization runs through year-end 2027.
Fluor reported third quarter 2025 revenue of $3.4 billion, down 18% from a year earlier, and a GAAP net loss attributable to Fluor of $697 million. The loss reflects a $653 million charge for the Santos ruling and a $401 million reduction tied to NuScale's share price, while adjusted EPS rose to $0.68 and the company raised its 2025 adjusted EPS and adjusted EBITDA guidance.
Q3 revenue was $3.4 billion, down 18% year over year, reflecting a $653 million reduction for the Santos ruling
Adjusted EPS was $0.68, up 33% year over year; GAAP EPS was ($4.30)
2025 adjusted EBITDA guidance raised to $510 million to $540 million from $475 million to $525 million
Q3 share repurchases were $70 million, with an additional $800 million targeted through February
ANI Pharmaceuticals reported third-quarter 2025 net revenues of $227.8 million, up 53.6% from a year earlier, and GAAP net income attributable to common shareholders of $26.3 million, or $1.13 per diluted share, compared with a loss of $1.27 per share in the prior-year quarter. The company raised its full-year 2025 total net revenue guidance to $854 million to $873 million and its adjusted non-GAAP EBITDA guidance to $221 million to $228 million, which points to higher expected results for shareholders.
Q3 2025 net revenues were $227.8 million, up 53.6% from $148.3 million in Q3 2024.
Cortrophin Gel net revenues were $101.9 million, up 93.8% year over year.
GAAP diluted EPS was $1.13 versus a loss of $1.27 a year earlier; adjusted non-GAAP diluted EPS was $2.04.
2025 total net revenue guidance was raised to $854 million to $873 million, from $818 million to $843 million; ILUVIEN net revenue was $16.6 million in the quarter, which the company said was pressured by reduced Medicare access.
Atmus Filtration Technologies reported third-quarter 2025 net sales of $448 million, up 10.9% from a year earlier, and diluted earnings per share of $0.66 versus $0.52. The company raised its full-year 2025 guidance and said it completed its operational separation from former parent Cummins Inc. For shareholders, the higher profit and raised outlook point to improved results, and the company also repurchased $30 million of its stock during the quarter.
Net sales of $448 million versus $404 million in the third quarter of 2024, an increase of 10.9%
GAAP net income of $55 million; diluted EPS of $0.66 versus $0.52; adjusted EPS of $0.69 versus $0.61
2025 guidance raised: revenue of $1,720 million to $1,745 million and adjusted EPS of $2.50 to $2.65
Repurchased $30 million of common stock; $69 million remained under the $150 million authorization as of September 30, 2025; quarterly dividend of $0.055 per share, up 10%
CNH Industrial reported third-quarter 2025 net income of $67 million and diluted EPS of $0.06, down from $310 million and $0.24 a year earlier, on consolidated revenues of $4.40 billion, down 5%. The company lowered its 2025 adjusted diluted EPS outlook to $0.44 to $0.50, citing tariff headwinds and an unfavorable geographic sales mix, while raising its net sales guidance.
Q3 2025 net income was $67 million versus $310 million in Q3 2024; diluted EPS was $0.06 versus $0.24.
Adjusted EBIT of Industrial Activities fell 69% to $104 million; Agriculture adjusted EBIT margin was 4.6%, down from 10.2%.
Updated 2025 outlook: adjusted diluted EPS of $0.44 to $0.50; Agriculture net sales down 11% to 13% year over year.
Free cash flow of Industrial Activities was negative $188 million in Q3 2025; 2025 full-year guidance is $200 million to $500 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.